Literature DB >> 26046821

Enhanced Adhesion of Stromal Cells to Invasive Cancer Cells Regulated by Cadherin 11.

Kathleen M McAndrews, Jaeyoon Yi, Daniel J McGrail, Michelle R Dawson1.   

Abstract

Cancer-associated fibroblasts (CAFs) are known to promote tumor growth and metastasis; however their differential accumulation in invasive and noninvasive tumors is not fully understood. We hypothesized that differences in cell adhesion may contribute to this phenomenon. To test this, we analyzed the adhesion of CAF-precursor fibroblasts and mesenchymal stem cells to invasive and noninvasive cancers originating from the the breast, ovaries, and prostate. In all cases, stromal cells preferentially adhered to more invasive cancer cells. Modulating integrin and cadherin binding affinities with calcium chelation revealed that adhesion was independent of integrin activity but required cadherin function. Invasive cancer cells had increased expression of mesenchymal markers cadherin 2 and 11 that localized with stromal cell cadherin 11, suggesting that these molecules are involved in stromal cell engraftment. Blockade of cadherin 11 on stromal cells inhibited adhesion and may serve as a target for metastatic disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26046821     DOI: 10.1021/acschembio.5b00353

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  9 in total

1.  Senescent mesenchymal stem cells remodel extracellular matrix driving breast cancer cells to a more-invasive phenotype.

Authors:  Deepraj Ghosh; Carolina Mejia Pena; Nhat Quach; Botai Xuan; Amy H Lee; Michelle R Dawson
Journal:  J Cell Sci       Date:  2020-01-23       Impact factor: 5.285

2.  Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.

Authors:  Shuai Chen; Yi Wei; Hanyang Liu; Yu Gong; Yan Zhou; Haojun Yang; Liming Tang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 3.  Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment.

Authors:  Tsz-Lun Yeung; Cecilia S Leung; Fuhai Li; Stephen S T Wong; Samuel C Mok
Journal:  Biomolecules       Date:  2016-01-06

4.  Ovarian Cancer Exosomes Trigger Differential Biophysical Response in Tumor-Derived Fibroblasts.

Authors:  Amy H Lee; Deepraj Ghosh; Nhat Quach; Devin Schroeder; Michelle R Dawson
Journal:  Sci Rep       Date:  2020-05-26       Impact factor: 4.379

5.  Co-expression network analysis identified CDH11 in association with progression and prognosis in gastric cancer.

Authors:  Peng-Fei Chen; Fan Wang; Jia-Yan Nie; Jue-Rong Feng; Jing Liu; Rui Zhou; Hong-Ling Wang; Qiu Zhao
Journal:  Onco Targets Ther       Date:  2018-10-02       Impact factor: 4.147

6.  DOK5 as a Prognostic Biomarker of Gastric Cancer Immunoinvasion: A Bioinformatics Analysis.

Authors:  Fengyong Luo; Zhihuai Wang; Shuai Chen; Zhenbo Luo; Gaochao Wang; Haojun Yang; Liming Tang
Journal:  Biomed Res Int       Date:  2022-01-05       Impact factor: 3.411

Review 7.  Fibrosis and cancer: A strained relationship.

Authors:  Bram Piersma; Mary-Kate Hayward; Valerie M Weaver
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-03-05       Impact factor: 11.414

8.  Mesenchymal Stem Cells Induce Directional Migration of Invasive Breast Cancer Cells through TGF-β.

Authors:  Kathleen M McAndrews; Daniel J McGrail; Nithin Ravikumar; Michelle R Dawson
Journal:  Sci Rep       Date:  2015-11-20       Impact factor: 4.379

9.  Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice.

Authors:  Hui-Hua Chang; Aune Moro; Kazuki Takakura; Hsin-Yuan Su; Allen Mo; Masako Nakanishi; Richard T Waldron; Samuel W French; David W Dawson; O Joe Hines; Gang Li; Vay Liang W Go; James Sinnett-Smith; Stephen J Pandol; Aurelia Lugea; Anna S Gukovskaya; Michael O Duff; Daniel W Rosenberg; Enrique Rozengurt; Guido Eibl
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.